HealthTree for Leukemia

HealthTree for Leukemia Together We Care. Together We Cure. Providing Resources to Take Control of Your Care and Contribute to Leukemia Cures.

This World Blood Cancer Day, we invite you to Be the reason 💜More than 192,000 people are expected to be diagnosed with ...
05/28/2026

This World Blood Cancer Day, we invite you to Be the reason 💜
More than 192,000 people are expected to be diagnosed with a blood cancer this year in the U.S. That’s someone every 3 minutes.
BE:
The reason patients find answers
The reason they feel supported
The reason they can take an active role in their care
At HealthTree Foundation, we provide education, community, and tools that support informed decision-making.
💛 Help raise awareness and support others
👉 Download and share the awareness toolkit: https://healthtree.org/myeloma/community/world-blood-cancer-day

05/27/2026

"We can own the pace of our own cure if we participate in research."
This Cancer Research Month, we invite you to be part of something that has never been done before.
At HealthTree, we turn scattered records into clean, trusted insights to accelerate blood cancer discoveries. Every survey you take, every record you share, and every experience you tell us about help bridge gaps in research to optimize care and personalize treatments.
If you want to learn more about how to participate in research, email [email protected] or call 800-709-1113, and our patient navigators can guide you on the best way to get started.

Mental Health Awareness Month, JOIN US👇Help someone today
05/23/2026

Mental Health Awareness Month, JOIN US
👇
Help someone today

Many people are starting to rethink how much red meat they eat and for good reason 🥩Research shows that high consumption...
05/22/2026

Many people are starting to rethink how much red meat they eat and for good reason 🥩
Research shows that high consumption of red and processed meats may be linked to an increased risk of certain cancers, particularly when consumed frequently over time. Factors like processing, cooking at high temperatures, and inflammation may all play a role.
The good news is that you don’t need to make extreme changes. Small shifts like choosing poultry or fish more often, limiting processed meats, and adjusting cooking methods can support your long-term health.
At HealthTree Foundation, we share research-backed insights to help you feel more confident in your health decisions.
👉 Read the full article here: https://healthtree.org/myeloma/community/articles/26-red-meat-and-cancer-risk?utm_source=&utm_medium=meta&utm_campaign=socialmedia&utm_content=general

Advances in AML treatment continue to reshape patient care. Learn from expert faculty as they discuss the role of IDH an...
05/21/2026

Advances in AML treatment continue to reshape patient care. Learn from expert faculty as they discuss the role of IDH and FLT3 mutations and share insights on targeted therapies and evolving treatment strategies. Save your spot today: https://activities.paradigmmc.com/1384AMLHealthTree

05/21/2026

Mental health is an essential part of cancer care 💚
As part of Mental Health Awareness Month, we are sharing key takeaways from our recent webinar with Dr. Meagan Dwyer on coping with the emotional challenges that can come with cancer.
From managing anxiety and stress to recognizing when it may be time to seek extra support, this conversation offered practical tools and compassionate guidance for both patients and caregivers.
One important reminder: what you are feeling is valid, common, and you do not have to go through it alone.
Watch the full webinar here: https://healthtree.org/blood-cancer/community/events/may26-mental-health-tools-blood-cancer?utm_source=&utm_medium=meta&utm_campaign=socialmedia&utm_content=general

On International Clinical Trial Day, we’re debunking the myths. Clinical trials provide access to tomorrow’s treatments,...
05/20/2026

On International Clinical Trial Day, we’re debunking the myths. Clinical trials provide access to tomorrow’s treatments, giving doctors the insights needed to fight cancer more effectively. Clinical research is the engine driving medical progress.
By joining a trial, you gain:
Early access to cutting-edge therapies.
Expert care from top-tier specialists.
A legacy of hope for future generations.
Check out HealthTree’s Clinical Trial Finder here to learn more: https://healthtree.org/blood-cancer/curehub/private/clinical-trials?utm_source=&utm_medium=meta&utm_campaign=socialmedia&utm_content=general

Sleep is a critical part of healing but it’s often overlooked in cancer care 😴Research shows that sleep supports immune ...
05/15/2026

Sleep is a critical part of healing but it’s often overlooked in cancer care 😴
Research shows that sleep supports immune function, tissue repair, and emotional well being. Yet many patients experience sleep problems during and after treatment.
Poor sleep can worsen fatigue, pain, and mood making it harder to recover and feel your best.
Understanding the role of sleep is an important step in improving your overall health.
At HealthTree Foundation, we’re sharing research backed insights to support patients through every stage of care.
👉 Read more here: https://healthtree.org/blood-cancer/community/articles/26-find-better-sleep-with-cancer?utm_source=&utm_medium=meta&utm_campaign=socialmediaorganic&utm_content=general

On May 13, 2026, the U.S. Food and Drug Administration (FDA) approved an all-oral combination of decitabine and cedazuri...
05/14/2026

On May 13, 2026, the U.S. Food and Drug Administration (FDA) approved an all-oral combination of decitabine and cedazuridine (Inqovi, Taiho Oncology) with venetoclax (Venclexta, AbbVie and Genentech) for adults with newly diagnosed acute myeloid leukemia (AML). The combination was approved for people 75 or older and those who are not eligible for intensive induction chemotherapy.

According to a Taiho Oncology press release, Dr. Harold Keer, MD, PhD, Chief Medical Officer of Taiho Oncology, shared that this approval represents an important step forward in expanding treatment options for this patient population by offering an all-oral approach that may help reduce the burden associated with hospital visits or infusion centers.

Read the full article here: https://healthtree.org/aml/community/articles/26-oral-decitabine-cedazuridine-venetoclax-aml?utm_source=&utm_medium=meta&utm_campaign=socialmedia&utm_content=general

Address

3315 Mayflower Way Suite 2
Lehi, UT

Telephone

+18009305159

Website

Alerts

Be the first to know and let us send you an email when HealthTree for Leukemia posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to HealthTree for Leukemia:

Shortcuts

Share

Category